HR 10150·Federal·house
Advancing Botanical Drug Development Act of 2026
In CommitteeFiled Aug 27, 2026
Sponsor: Rep. Boebert, Lauren [R-CO-4] (R)
Latest Action
Referred to the House Committee on Energy and Commerce.
Aug 27, 2026
Summary
The bill changes federal drug law so that products derived from plants can enjoy a set time of exclusive market rights. This would affect companies that develop botanical medicines and could encourage more research into plant‑based treatments. It is currently referred to the House Energy and Commerce Committee.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HR 10150 changes status, plus AI-powered summaries and stage predictions.
Sign up free